Huntington National Bank’s TherapeuticsMD TXMD Stock Holding History

Huntington National Bank’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242	Hold	120	–	–	﹤0.01%	2493
2025 Q4	$196	Hold	120	–	–	﹤0.01%	2440
2025 Q3	$129	Hold	120	–	–	﹤0.01%	2582
2025 Q2	$139	Hold	120	–	–	﹤0.01%	2626
2025 Q1	$111	Hold	120	–	–	﹤0.01%	2690
2024 Q4	$103	Hold	120	–	–	﹤0.01%	2724
2024 Q3	$199	Hold	120	–	–	﹤0.01%	2660
2024 Q2	$193	Hold	120	–	–	﹤0.01%	2616
2024 Q1	$275	Hold	120	–	–	﹤0.01%	2412
2023 Q4	$270	Hold	120	–	–	﹤0.01%	2330
2023 Q3	$362	Hold	120	–	–	﹤0.01%	2286
2023 Q2	$494	Hold	120	–	–	﹤0.01%	2226
2023 Q1	$450	Hold	120	–	–	﹤0.01%	2091
2022 Q4	$671	Hold	120	–	–	﹤0.01%	1898
2022 Q3	$0	Hold	120	–	–	﹤0.01%	2399
2022 Q2	$1K	Hold	120	–	–	﹤0.01%	1985
2022 Q1	$2K	Hold	120	–	–	﹤0.01%	1929
2021 Q4	$2K	Hold	120	–	–	﹤0.01%	1916
2021 Q3	$4K	Hold	120	–	–	﹤0.01%	1606
2021 Q2	$7K	Hold	120	–	–	﹤0.01%	1514
2021 Q1	$8K	Hold	120	–	–	﹤0.01%	1388
2020 Q4	$7K	Hold	120	–	–	﹤0.01%	1361
2020 Q3	$9K	Hold	120	–	–	﹤0.01%	1252
2020 Q2	$8K	Hold	120	–	–	﹤0.01%	1258
2020 Q1	$6K	Hold	120	–	–	﹤0.01%	1308
2019 Q4	$15K	Hold	120	–	–	﹤0.01%	1337
2019 Q3	$22K	Hold	120	–	–	﹤0.01%	1092
2019 Q2	$16K	Hold	120	–	–	﹤0.01%	1218
2019 Q1	$29K	Hold	120	–	–	﹤0.01%	1022
2018 Q4	$23K	Hold	120	–	–	﹤0.01%	1100
2018 Q3	$39K	Hold	120	–	–	﹤0.01%	1058
2018 Q2	$37K	Hold	120	–	–	﹤0.01%	1055
2018 Q1	$29K	Hold	120	–	–	﹤0.01%	1119
2017 Q4	$36K	Hold	120	–	–	﹤0.01%	1060
2017 Q3	$32K	Hold	120	–	–	﹤0.01%	1097
2017 Q2	$32K	Hold	120	–	–	﹤0.01%	1056
2017 Q1	$43K	Hold	120	–	–	﹤0.01%	935
2016 Q4	$35K	Hold	120	–	–	﹤0.01%	998
2016 Q3	$41K	Hold	120	–	–	﹤0.01%	971
2016 Q2	$51K	Buy	120 +60	+100%	+$24.7K	﹤0.01%	915
2016 Q1	$18K	Sell	60 -60	-50%	-$20.5K	﹤0.01%	1384
2015 Q4	$62K	Hold	120	–	–	﹤0.01%	960
2015 Q3	$35K	Buy	120 +40	+50%	+$14.2K	﹤0.01%	1116
2015 Q2	$31K	Buy	80 +20	+33%	+$7.06K	﹤0.01%	1233
2015 Q1	$18K	Hold	60	–	–	﹤0.01%	1389
2014 Q4	$13K	Buy	+60	New	+$12.4K	﹤0.01%	1420

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Huntington National Bank's TXMD Position: Q1 2026 in Review

Huntington National Bank held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 120 shares worth $242. The position accounts for ﹤0.01% of the portfolio, ranked #2493.

Huntington National Bank first reported a position in TXMD in Q4 2014 and has held it in 46 quarters since. The position peaked at $62K in Q4 2015. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

Huntington National Bank held 120 shares of TherapeuticsMD worth $242 as of Q1 2026.
Huntington National Bank left its TherapeuticsMD share count unchanged in Q1 2026.
TherapeuticsMD made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2493 holding.
Huntington National Bank first reported a position in TherapeuticsMD in Q4 2014 and has held it in 46 quarters since.
Huntington National Bank's TherapeuticsMD position peaked at $62K in Q4 2015.
49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.